Evidence map›Paper›PMID 16091144›Full record

ArticleFilaria journal2005

Studies on Acanthocheilonema viteae cystatin: genomic organization, promoter studies and expression in Caenorhabditis elegans.

Smitha Pillai, Bernd H Kalinna, Eva Liebau, Susanne Hartmann, Franz Theuring, Richard Lucius

Open access · hybridAbstract read
In one paragraph

Article in Filaria journal, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Smitha Pillai *Department of Molecular Parasitology, Institute of Biology, Humboldt University Berlin, 10115 Berlin, Germany.
Bernd H Kalinna *Department of Molecular Parasitology, Institute of Biology, Humboldt University Berlin, 10115 Berlin, Germany.
Eva LiebauDepartment of Biochemistry, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany.
Susanne HartmannDepartment of Molecular Parasitology, Institute of Biology, Humboldt University Berlin, 10115 Berlin, Germany.
Franz TheuringInstitute for Pharmacology and Toxicology, Charitée, 10115 Berlin, Germany.
Richard LuciusDepartment of Molecular Parasitology, Institute of Biology, Humboldt University Berlin, 10115 Berlin, Germany.
Humboldt-Universität zu Berlin · DEBernhard Nocht Institute for Tropical Medicine · DECharité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystatins are reversible, tightly binding inhibitors of cysteine proteases. Filarial cystatins have been ascribed immunomodulatory properties and have been implicated in protective immunity. To continue exploration of this potential, here we have determined the sequence, structure and genomic organization of the cystatin gene locus of A. viteae. The gene is composed of 4 exons separated by 3 introns and spans approximately 2 kb of genomic DNA. The upstream genomic sequence contains transcriptional factor binding sites such as AP-1 and NF-Y, an inverted CCAAT sequence, and a TATA box. To investigate sites of cystatin expression, Caenorhabditis elegans worms were transformed by microinjection with the putative promoter region and the first exon of the A. viteae cystatin gene fused to the reporter GFP. In transgenic worms fluorescence was observed in the pharyngeal and rectal gland cells suggesting that cystatin is secreted. Additionally, A. viteae cystatin was expressed in C. elegans to explore its potential as an expression system for filarial genes.

Identifiers

PMID16091144
PMCPMC1187909
OpenAlexW2111796749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.